Journal reference: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
In 2023, Chun Sing Lau et al
10.1080/17512433.2020.1736041 32 StorgaardH.ColdF.GluudL
Before a single dose of tirzepatide or semaglutide is ordered, you get a deep look at hormones, micronutrients, inflammation, liver health, insulin dynamics, and cardiovascular risk so the protocol is built around your actual biology, not an average trial patient. Bring the fatigue, the Ive tried everything, and the halffinished injections in your fridge
Use semaglutide 1 time each week, on the same day each week, at any time of the day